Skip to main content

Table 2 Characteristics of patients according to ESBL-producing K. pneumoniae BSI from January 1996 to May 2001.

From: Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum β-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence

Variables

ESBL (n = 56)

Non-ESBL (n = 52)

 
 

N

%

N

%

P

AGE (infants)

   <1 year

17

54.8

14

45.2

0.693

   ≥ 1 year

39

50.6

38

49.4

 

AGE (elderly)

   >60 years

11

57.9

8

42.1

0.561

   < = 60 years

45

50.6

44

49.4

 

SEX

   Male

25

47.2

28

52.8

0.339

   Female

31

56.4

24

43.6

 

HOSPITAL LOCATION

   ICU

31

63.3

18

36.7

0.031

   Other units

25

42.4

34

57.6

 

HOSPITAL STAY (days)

   >10 days

50

56.2

39

43.8

0.051

   < = 10 days

6

31.6

13

68.4

 

CENTRAL VENOUS CATHETER

   0

29

44.6

36

55.4

0.044

   1

23

60.5

15

39.5

 

   ≥ 2

4

80.0

1

20.0

 

SWAN-GANZ

   Yes

2

66.7

1

33.3

1.000

   No

54

51.4

51

48.6

 

HEMODIALYSIS

   Yes

4

66.7

2

33.3

0.680

   No

52

51.0

50

49.0

 

URINARY CATHETER

   Yes

11

68.8

5

31.3

0.143

   No

45

48.9

47

54.0

 

MECHANICAL VENTILATION

   Yes

16

76.2

5

23.8

0.013

   No

40

46.0

47

54.0

 

DRAINAGE TUBES

   Yes

5

83.3

1

16.7

0.207

   No

51

50.0

51

50.0

 

PREVIOUS ANTIBIOTICS

   0

15

31.3

33

68.8

0.276

   1

17

73.9

6

26.1

 

   2

14

56.0

11

44.0

 

   ≥ 3

10

83.3

2

16.7

 

McCabe CLASSIFICATION

   Rapidly fatal

9

52.9

8

47.1

0.623

   Potentially fatal

6

37.5

10

62.5

 

   Non fatal

41

54.7

34

45.3

 

NUMBER OF COMORBIDITIES

   None

19

51.4

18

48.6

0.662

   1

20

47.6

22

52.4

 

   2

14

58.3

10

41.7

 

   3

3

75.0

1

25.0

 

   4

0

-

1

100.0

 

SOURCE OF BSI

   Respiratory

23

56.1

18

43.9

0.343

   Abdominal

12

42.9

16

57.1

 

   Urinary

8

66.7

4

33.3

 

   Catheter

6

40.0

9

60.0

 

   CNS

3

75.0

1

25.0

 

   Wound

2

100.0

0

-

 

   Abdominal

12

42.9

16

57.1

 

   Others

2

33.3

4

66.7

 

SEPTIC SHOCK

   Yes

10

45.5

12

54.5

0.501

   No

46

53.5

40

46.5

 

PLATELETS

   ≥ 80,000/mm3

31

50.8

30

49.2

0.438

   <80,000/mm3

15

32.6

10

25.0

 

ANTIBIOTIC THERAPY

   Adequate

33

47.8

36

52.2

0.265

   Inadequate

23

41.1

16

30.8

 

15 DAY-MORTALITY

   Yes

18

69.2

8

30.8

0.042

   No

38

46.3

44

53.7

 

TIME TRENDS IN MORTALITY

   1996–1998

21

55.3

17

44.7

0.601

   1999–2001

35

50.0

35

50.0